DCRI Researchers Weigh In On Wearables in Heart Failure Care
Researchers from the DCRI are optimistic about the opportunities that wearable devices present in caring for patients with heart failure; however, they also recognize that challenges must be overcome to successfully interpret and act upon patient data collected from wearables.
Tool to Assess Cardiovascular Risk May be Inaccurate in Older Adults
A DCRI-led study is the first to test the performance of the Pooled Cohort Risk Equations, a commonly used tool for assessing cardiovascular risk, in older adults.
DCRI Pediatrician Contributes to Guidance on Pediatric Weight-Loss Surgery
The DCRI’s Sarah Armstrong, MD, served as the lead author for a policy statement and a co-author on a technical report advocating for more widespread use of bariatric and metabolic surgeries for ch
Study Suggests Strokes May be Treated Differently than Heart Attacks
A recent study from DCRI researchers found that patients who have had strokes may receive different care than those who have had heart attacks, despite evidence that shows statins are effective for secondary prevention in both populations to prevent recurring ischemic events.
DCRI’s Piccini Weighs in on Catheter Ablation in Cardiology Today
Mixed results from the CABANA trial have led to debate about whether catheter ablation is an effective treatment option that provides benefit to patients with atrial fibrillation.
Differences in Patient Beliefs May Play Role in Women’s Underuse of Statins
Women are less likely than men to receive statins, and those who do receive statins are more likely to receive a prescription below recommended guidelines. DCRI fellow Michael Nanna, MD (pictured), examined patient data from the PALM (Patient and Provider Assessment of Lipid Management) Registry in an effort to ascertain reasons for these differences. He and his team found that women are offered statins at lower rates but refuse or discontinue statins at higher rates than men.
Implantable Cardioverter Defibrillators Still Important in Clinical Practice
Evidence supports that implantable cardioverter defibrillators still provide life-saving benefits, but more research is needed to improve the selection of patients for this treatment. Although it is incorrect to discount the potential benefit of implantable cardioverter defibrillators, it is also critical to improve selection criteria for patients who would derive the most benefit, writes the DCRI’s Sana Al-Khatib, MD, in two recent pieces on the topic.
DCRI Study Applies ACC/AHA Guidelines on Cholesterol Management
A study led by a DCRI faculty member provides additional clarification on which patients may benefit the most from additional lipid-lowering therapies, if their cholesterol levels remain elevated despite optimal statin therapy.
Hyperlipidemia Not Associated With Cardiovascular Risk in Older Adults
Recent findings suggest that elevations in low-density lipoprotein cholesterol levels may not confer additional risk in populations 75 or older.
DCRI Study Finds New Predictor of Health Care Costs
New findings from the DCRI suggest that how military service members interpret their pain may be able to predict pain-related costs and total medical costs.